Genethon France is a leading brand that specializes in developing innovative therapies for rare diseases. Their expertise lies in treating conditions related to the eye, liver, immune system, and neuromuscular disorders. Through their cutting-edge gene therapy treatments, Genethon aims to advance medical solutions for these complex and often debilitating diseases.

With a team of dedicated researchers and state-of-the-art platforms, Genethon is at the forefront of scientific advancements in gene therapy. They focus on various areas of research, including progressive muscular dystrophies, neuromuscular diseases, gene editing, immunology, and liver diseases. One of Genethon's key initiatives is their DNA Bank, which plays a crucial role in supporting their research endeavors.

This bank enables them to store and analyze genetic material, furthering their understanding of rare diseases and aiding in the development of targeted treatments. As a brand, Genethon is committed to providing access to treatments for rare diseases and actively engages with the public through informative initiatives such as The DNA School. Through their partnerships and collaborations with other organizations, Genethon strives to make a positive impact on the lives of those affected by rare diseases